Vitasora Health Completes A$11m Raise to Drive U.S. Connected Care Expansion

The latest update is out from Vitasora Health ( (AU:VHL) ).

Vitasora Health has completed an A$11 million capital raise, including full receipt of a previously announced A$6.75 million cornerstone investment and earlier strategic placements, materially strengthening its balance sheet and funding position. The fresh capital will support the company’s U.S. growth strategy, including investment in automation and AI-enabled enrolment tools, scaling of Connected Care programs for existing and new clients, and the ramp-up of high-volume Medicaid and fee-for-service initiatives with partners such as Iris Health, Tampa Family Health Centers and Family Care in West Virginia. Operationally, Vitasora reported growing active patient programs, rapid enrolments under new partnerships and an expanding U.S. sales pipeline, and its board believes the reinforced capital base leaves the company well positioned to pursue its expansion and achieve cash-flow breakeven by the end of FY2026, potentially enhancing its competitive standing in the U.S. remote care market.

The most recent analyst rating on (AU:VHL) stock is a Sell with a A$0.03 price target. To see the full list of analyst forecasts on Vitasora Health stock, see the AU:VHL Stock Forecast page.

More about Vitasora Health

Vitasora Health Limited is an Australia-listed digital healthcare company focused on the U.S. market, providing connected care solutions such as remote patient monitoring (RPM) and chronic care management (CCM). It combines technology and clinical teams to deliver turnkey remote healthcare services aimed at improving outcomes, reducing costs and supporting providers operating in value-based care models across Medicare, Medicaid and fee-for-service programs.

Average Trading Volume: 2,308,761

Technical Sentiment Signal: Sell

Current Market Cap: A$39.02M

Learn more about VHL stock on TipRanks’ Stock Analysis page.